CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023		164,279
Beginning balance at Dec. 31, 2023	$ 420,236	$ 164	$ 764,344	$ (32)	$ (344,240)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		16
Issuance of common stock	92	$ 0	92
Share repurchase (in shares)		(99)
Share repurchase	(598)		(598)
Equity-based compensation (in shares)		416
Equity-based compensation	2,682	$ 1	2,681
Unrealized gain (loss) on available for sale debt securities	18			18
Cumulative translation adjustment	16			16
Net income (loss)	(85,607)				(85,607)
Ending balance (in shares) at Mar. 31, 2024		164,612
Ending balance at Mar. 31, 2024	$ 336,839	$ 165	766,519	2	(429,847)
Beginning balance (in shares) at Dec. 31, 2024	173,566	173,566
Beginning balance at Dec. 31, 2024	$ 180,449	$ 174	813,573	78	(633,376)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		4,091
Issuance of common stock	33,152	$ 4	33,148
Warrants exercised (in shares)		1,511
Warrants exercised	14,217	$ 1	14,216
Share repurchase (in shares)		(187)
Share repurchase	(1,697)	$ 0	(1,697)
Equity-based compensation (in shares)		554
Equity-based compensation	3,354	$ 1	3,353
Unrealized gain (loss) on available for sale debt securities	0
Cumulative translation adjustment	(94)			(94)
Net income (loss)	$ 8,832				8,832
Ending balance (in shares) at Mar. 31, 2025	179,535	179,535
Ending balance at Mar. 31, 2025	$ 238,213	$ 180	$ 862,593	$ (16)	$ (624,544)